ABIVAX Société Anonyme (EPA:ABVX)
94.00
-5.10 (-5.15%)
At close: Mar 6, 2026
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
€79,269
Profits / Employee
€4,380,896
Market Cap
7.32B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Nanobiotix | 103 |
| DBV Technologies | 117 |
| Inventiva | 84 |
| Valneva SE | 700 |
| MedinCell | 145 |
| Genfit | 188 |
| Cellectis | 222 |
| Transgene | 147 |
ABIVAX Société Anonyme News
- 8 days ago - 2 Reasons Abivax Stock Could 10X by 2036 - The Motley Fool
- 10 days ago - BTIG Reiterates Buy Rating for Abivax (ABVX) with $150 Price Target | ABVX Stock News - GuruFocus
- 11 days ago - Wedbush Rates Abivax (ABVX) as Underperform with Cautious Outlook - GuruFocus
- 13 days ago - Abivax (ABVX) Highlights Promising Obefazimod Data at ECCO Congress - GuruFocus
- 14 days ago - Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 - GlobeNewsWire
- 18 days ago - Alger Mid Cap Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 25 days ago - Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - The Motley Fool
- 5 weeks ago - Better Long-Term Buy: This Emerging Player or the Industry Leader? - The Motley Fool